Symbiotica Speciality Ingredients Sdn.Bhd is an API manufacturer based in Malaysia. It holds 7 active US drug master files across a filed portfolio of 10 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 16 May 2025 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Malaysia, Malaysia | 3006464546 |
| Molecule | Regulators | Docs |
|---|---|---|
| Dexamethasone | SFDA (Saudi Arabia), US FDA | 2 |
| Prednisolone | SFDA (Saudi Arabia) | 2 |
| Betamethasone | US FDA | 1 |
| Betamethasone Dipropionate | SFDA (Saudi Arabia) | 1 |
| Calcipotriol | SFDA (Saudi Arabia) | 1 |
| Clobetasol Propionate | US FDA | 1 |
| Exemestane | US FDA | 1 |
| Halobetasol Propionate | US FDA | 1 |
| Hydrocortisone | US FDA | 1 |
| Mometasone Furoate | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Ask Fred what the record holds on Symbiotica Speciality Ingredients Sdn.Bhd, including filings and inspection history.
Chat with Fred, your AI analystRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.